Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study.
Jaworski J, Matucci-Cerinic M, Schulze-Koops H, Buch MH, Kucharz EJ, Allanore Y, Kavanaugh A, Young P, Babic G. Jaworski J, et al. Among authors: young p. Arthritis Res Ther. 2019 May 28;21(1):130. doi: 10.1186/s13075-019-1907-x. Arthritis Res Ther. 2019. PMID: 31138316 Free PMC article. Clinical Trial.
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.
Greenberg RN, Hay CM, Stapleton JT, Marbury TC, Wagner E, Kreitmeir E, Röesch S, von Krempelhuber A, Young P, Nichols R, Meyer TP, Schmidt D, Weigl J, Virgin G, Arndtz-Wiedemann N, Chaplin P. Greenberg RN, et al. Among authors: young p. PLoS One. 2016 Jun 21;11(6):e0157335. doi: 10.1371/journal.pone.0157335. eCollection 2016. PLoS One. 2016. PMID: 27327616 Free PMC article. Clinical Trial.
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial.
Overton ET, Lawrence SJ, Wagner E, Nopora K, Rösch S, Young P, Schmidt D, Kreusel C, De Carli S, Meyer TP, Weidenthaler H, Samy N, Chaplin P. Overton ET, et al. Among authors: young p. PLoS One. 2018 Apr 13;13(4):e0195897. doi: 10.1371/journal.pone.0195897. eCollection 2018. PLoS One. 2018. PMID: 29652929 Free PMC article. Clinical Trial.
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.
Overton ET, Stapleton J, Frank I, Hassler S, Goepfert PA, Barker D, Wagner E, von Krempelhuber A, Virgin G, Meyer TP, Müller J, Bädeker N, Grünert R, Young P, Rösch S, Maclennan J, Arndtz-Wiedemann N, Chaplin P. Overton ET, et al. Among authors: young p. Open Forum Infect Dis. 2015 May 5;2(2):ofv040. doi: 10.1093/ofid/ofv040. eCollection 2015 Apr. Open Forum Infect Dis. 2015. PMID: 26380340 Free PMC article.
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.
Greenberg RN, Hurley MY, Dinh DV, Mraz S, Vera JG, von Bredow D, von Krempelhuber A, Roesch S, Virgin G, Arndtz-Wiedemann N, Meyer TP, Schmidt D, Nichols R, Young P, Chaplin P. Greenberg RN, et al. Among authors: young p. PLoS One. 2015 Oct 6;10(10):e0138348. doi: 10.1371/journal.pone.0138348. eCollection 2015. PLoS One. 2015. PMID: 26439129 Free PMC article. Clinical Trial.
Adverse events during and after early mobilisation: A post hoc analysis of the TEAM trial.
Broadley T, Serpa Neto A, Bailey M, Bellomo R, Brickell K, Buhr H, Gabbe BJ, Gould DW, Harrold M, Hurford S, Iwashyna TJ, Nichol AD, Presneill JJ, Schaller SJ, Sivasuthan J, Tipping CJ, Webb S, Young PJ, Higgins AM, Hodgson CL; TEAM Trial Investigators. Broadley T, et al. Among authors: young pj. Aust Crit Care. 2025 Jan 17;38(3):101156. doi: 10.1016/j.aucc.2024.101156. Online ahead of print. Aust Crit Care. 2025. PMID: 39826257
Timing of adjunctive vasopressin initiation for septic shock patients and hospital mortality: A multicentre observational study.
White KC, Costa-Pinto R, Chaba A, McIlroy P, Senthuran S, Luke S, Attokaran AG, Garrett P, Ramanan M, Tabah A, Shekar K, Laupland KB, White H, McCullough J, Udy A, Eastwood G, Bellomo R; Queensland Critical Care Research Network (QCCRN). White KC, et al. Crit Care Resusc. 2024 Nov 22;26(4):295-302. doi: 10.1016/j.ccrj.2024.09.002. eCollection 2024 Dec. Crit Care Resusc. 2024. PMID: 39781491 Free PMC article.
ICU-acquired hypernatremia: Prevalence, patient characteristics, trajectory, risk factors, and outcomes.
Nasser A, Chaba A, Laupland KB, Ramanan M, Tabah A, Attokaran AG, Kumar A, McCullough J, Shekar K, Garrett P, McIlroy P, Luke S, Senthuran S, Bellomo R, White KC; Queensland Critical Care Research Network (QCCRN). Nasser A, et al. Crit Care Resusc. 2024 Nov 22;26(4):303-310. doi: 10.1016/j.ccrj.2024.09.003. eCollection 2024 Dec. Crit Care Resusc. 2024. PMID: 39781488 Free PMC article.
3,591 results